Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/10926
Full metadata record
DC FieldValueLanguage
dc.contributor.authorForde, Brianen
dc.contributor.authorBergh, Haakonen
dc.contributor.authorCuddihy, Thomen
dc.contributor.authorHajkowicz, Krispinen
dc.contributor.authorHurst, Trishen
dc.contributor.authorPlayford, E. Geoffreyen
dc.contributor.authorHenderson. Belinda C.en
dc.contributor.authorRunnegar, Naomien
dc.contributor.authorClark, Juliaen
dc.contributor.authorJennison, Amyen
dc.contributor.authorMoss, Susanen
dc.contributor.authorHume, Annaen
dc.contributor.authorLeroux, Hugoen
dc.contributor.authorBeatson, Scott Aen
dc.contributor.authorPaterson, David Len
dc.contributor.authorHarris, Patrick NAen
dc.date.accessioned2026-05-27T01:24:12Z-
dc.date.available2026-05-27T01:24:12Z-
dc.date.issued2022-05-03-
dc.identifier.citationClin Infect Dis., vol 76, issue 3, 1 Feb 2023en
dc.identifier.urihttps://dora.health.qld.gov.au/qldresearchjspui/handle/1/10926-
dc.descriptionAcknowledgments. The authors thank the scientists at Pathology Queensland and Forensic and Scientific Services for their assistance in the laboratory work and the infection control teams at the participating hospitals for their involvement and clinical input. Data availability. All genomes derived from this project are publicly available at NCBI Bioproject PRJNA797179: https://www.ncbi.nlm.nih.gov/bioproject/PRJNA797179. Supplementary Data: Supplementary Table 1 (clinical meta-data) and Supplementary Table 2 (antimicrobial resistance genes) can be accessed via Harvard Dataverse (https://doi.org/10.7910/DVN/NOUWZY). Ethics. Ethical oversight was provided by The Forensic and Scientific Services Human Ethics Committee (reference HEC17_17) as a Low and Negligible Risk approval, with provision for a waiver of individual patient consent. Financial support. This work was supported by funding from the Queensland Genomics Health Alliance (now Queensland Genomics), Queensland Health, the Queensland Government. P. N. A. H. was supported by a National Health and Medical Research Council Early Career Fellowship Grant (grant number GNT1157530).en
dc.description.abstractBackground: Prospective whole-genome sequencing (WGS)-based surveillance may be the optimal approach to rapidly identify transmission of multi-drug resistant (MDR) bacteria in the healthcare setting. Methods: We prospectively collected methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), carbapenem-resistant Acinetobacter baumannii (CRAB), extended-spectrum beta-lactamase (ESBL-E), and carbapenemase-producing Enterobacterales (CPE) isolated from blood cultures, sterile sites, or screening specimens across three large tertiary referral hospitals (2 adult, 1 paediatric) in Brisbane, Australia. WGS was used to determine in silico multi-locus sequence typing (MLST) and resistance gene profiling via a bespoke genomic analysis pipeline. Putative transmission events were identified by comparison of core genome single nucleotide polymorphisms (SNPs). Relevant clinical meta-data were combined with genomic analyses via customised automation, collated into hospital-specific reports regularly distributed to infection control teams. Results: Over 4 years (April 2017 to July 2021) 2660 isolates were sequenced. This included MDR gram-negative bacilli (n = 293 CPE, n = 1309 ESBL), MRSA (n = 620), and VRE (n = 433). A total of 379 clinical reports were issued. Core genome SNP data identified that 33% of isolates formed 76 distinct clusters. Of the 76 clusters, 43 were contained to the 3 target hospitals, suggesting ongoing transmission within the clinical environment. The remaining 33 clusters represented possible inter-hospital transmission events or strains circulating in the community. In 1 hospital, proven negligible transmission of non-multi-resistant MRSA enabled changes to infection control policy. Conclusions: Implementation of routine WGS for MDR pathogens in clinical laboratories is feasible and can enable targeted infection prevention and control interventions.en
dc.publisherCold Spring Harbor Laboratoryen
dc.relation.ispartofClinical Infectious Diseasesen
dc.subjectMethicillin-Resistant Staphylococcus aureusen
dc.subjecthealthcare-associated infectionsen
dc.subjectwhole genome sequencingen
dc.subjectclinical implementationen
dc.subjectinfection prevention and controlen
dc.subjectMultilocus Sequence Typingen
dc.subjectAnti-Bacterial Agentsen
dc.titleClinical implementation of routine whole-genome sequencing for hospital infection control of multi-drug resistant pathogensen
dc.typeJournal articleen
dc.identifier.doi10.1101/2022.05.02.22273921-
dc.identifier.doi10.1093/cid/ciac726-
dc.rights.holderJennison, Amyen
dc.identifier.external112453528-
item.openairetypeJournal article-
item.cerifentitytypePublications-
item.fulltextWith Fulltext-
item.grantfulltextopen-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Sites:Forensic and Scientific Services Publications
Queensland Health Publications
Files in This Item:
File Description SizeFormat 
ciac726-1.pdfForde et al 2023703.76 kBAdobe PDFThumbnail
View/Open
Show simple item record

Page view(s)

220
checked on Sep 22, 2026

Download(s)

136
checked on Sep 22, 2026

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.